David Harpole
Duke Medical Center(US)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Cancer Genomics and Diagnostics, Pleural and Pulmonary Diseases, Occupational and environmental lung diseases, Gene expression and cancer classification
Most-Cited Works
- → Oncogenic pathway signatures in human cancers as a guide to targeted therapies(2005)2,062 cited
- → Genomic signatures to guide the use of chemotherapeutics(2006)593 cited
- → Transthoracic versus transhiatal esophagectomy: A prospective study of 945 patients(2003)160 cited
- → Comparison of Methods of Measuring HER-2 in Metastatic Breast Cancer Patients Treated With High-Dose Chemotherapy(2001)97 cited
- Role of serum tumor markers CA 125 and CEA in non-small cell lung cancer.(2001)
- → A Proposed System Toward Standardizing Surgical-Based Treatments for Malignant Pleural Mesothelioma, From the Joint National Cancer Institute–International Association for the Study of Lung Cancer–Mesothelioma Applied Research Foundation Taskforce(2019)50 cited
- → Role of serum tumor markers CA125 and CEA in non-small cell lung cancer(2000)49 cited
- → Retraction Note: Genomic signatures to guide the use of chemotherapeutics(2011)45 cited
- → Methemoglobinemia complicating topical anesthesia during bronchoscopic procedures(1997)31 cited
- → P1.18-02 The AEGEAN Phase 3 Trial of Neoadjuvant/Adjuvant Durvalumab in Patients with Resectable Stage II/III NSCLC(2019)22 cited